Frazier Lifesciences Acquisition 10-K 25 Mar 22 2021 FY Annual report Financial data

Cover Page

Cover Page - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Mar. 24, 2022	Jun. 30, 2021
Document Information [Line Items]
Document Type	10-K
Amendment Flag	false
Document Annual Report	true
Document Transition Report	false
Entity Registrant Name	FRAZIER LIFESCIENCES ACQUISITION CORPORATION
Entity Central Index Key	0001828326
Document Period End Date	Dec. 31, 2021
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	FY
Current Fiscal Year End Date	--12-31
Entity Incorporation, State or Country Code	E9
Entity File Number	001-39765
Entity Tax Identification Number	98-1562203
Entity Address, Address Line One	Two Union Square
Entity Address, Address Line Two	601 Union St., Suite 3200
Entity Address, City or Town	Seattle
Entity Address, State or Province	WA
Entity Address, Postal Zip Code	9810
City Area Code	206
Local Phone Number	621-7200
Title of 12(b) Security	Class A ordinary shares, par value $0.0001 per share
Trading Symbol	FLAC
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	true
Entity Well-known Seasoned Issuer	No
Entity Public Float			$ 143,720
Entity Voluntary Filers	No
ICFR Auditor Attestation Flag	false
Auditor Name	WithumSmith+Brown, PC
Auditor Firm ID	100
Auditor Location	506 Carnegie Center, Suite 400, Princeton, NJ 08540
Units, each consisting of one Class A ordinary share and one-third of a Warrant to acquire one Class A ordinary share [Member]
Document Information [Line Items]
Title of 12(b) Security	Units, each consisting of one Class A ordinary share and one-third of a Warrant to acquire one Class A ordinary share
Trading Symbol	FLACU
Security Exchange Name	NASDAQ
Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
Document Information [Line Items]
Title of 12(b) Security	Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
Trading Symbol	FLACW
Security Exchange Name	NASDAQ
Common Class A [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		14,301,000
Common Class B [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		3,450,000

Balance Sheets

Balance Sheets - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Current assets
Cash	$ 1,226,716	$ 1,365,094
Prepaid expenses	261,333	503,683
Total current assets	1,488,049	1,868,777
Investments held in Trust Account	138,017,009	138,000,851
Total Assets	139,505,058	139,869,628
Current liabilities
Accounts payable	167,324	162,478
Accrued expenses	54,750	74,043
Total current liabilities	222,074	236,521
Deferred underwriting commissions	4,830,000	4,830,000
Derivative warrant liabilities	2,812,530	7,341,180
Total liabilities	7,864,604	12,407,701
Commitments and Contingencies
Class A ordinary shares subject to possible redemption, $0.0001 par value; 13,800,000 shares issued and outstanding at redemption value of $10.00 per share at December 31, 2021 and 2020	138,000,000	138,000,000
Shareholders' Deficit:
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding at December 31, 2021 and 2020
Additional paid-in capital	0	0
Accumulated deficit	(6,359,941)	(10,538,468)
Total shareholders' deficit	(6,359,546)	(10,538,073)
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders' Deficit	139,505,058	139,869,628
Common Class A [Member]
Current liabilities
Class A ordinary shares subject to possible redemption, $0.0001 par value; 13,800,000 shares issued and outstanding at redemption value of $10.00 per share at December 31, 2021 and 2020	138,000,000
Shareholders' Deficit:
Common Stock	50	50
Common Class B [Member]
Shareholders' Deficit:
Common Stock	$ 345	$ 345

Balance Sheet (Parenthetical)

Balance Sheet (Parenthetical) - $ / shares	Dec. 31, 2021	Dec. 31, 2020	Dec. 08, 2020	Dec. 07, 2020	Oct. 07, 2020
Temporary equity par or stated value per share	$ 0.0001	$ 0.0001
Temporary Equity, Shares Issued	13,800,000	13,800,000
Temporary equity shares outstanding	13,800,000	13,800,000
Temporary equity redemption price per share	$ 10	$ 10
Preferred stock par or stated value per share	$ 0.0001	$ 0.0001
Preferred stock shares authorized	1,000,000	1,000,000
Preferred stock shares issued	0	0
Preferred stock shares outstanding	0	0
Common Class A [Member]
Temporary equity par or stated value per share	$ 0.0001
Temporary Equity, Shares Issued	13,800,000
Temporary equity shares outstanding	13,800,000	13,800,000
Common stock par or stated value per share	$ 0.0001	$ 0.0001
Common stock shares authorized	479,000,000	479,000,000
Common stock shares issued	501,000	501,000
Common stock shares outstanding	501,000	501,000
Common Class B [Member]
Common stock par or stated value per share	$ 0.0001	$ 0.0001
Common stock shares authorized	20,000,000	20,000,000
Common stock shares issued	3,450,000	3,450,000			2,875,000
Common stock shares outstanding	3,450,000	3,450,000	3,450,000	2,875,000

Statements of Operations

Statements of Operations - USD ($)	3 Months Ended	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2021
General and administrative expenses	$ 120,884	$ 1,246,281
Administrative expenses - related party	6,774	120,000
Loss from operations	(127,658)	(1,366,281)
Other income (expenses)
Net gain from investments held in Trust Account	851	16,158
Change in fair value of derivative warrant liabilities	619,710	4,528,650
Break-up fee from terminated agreement	0	1,000,000
Financing costs—derivative warrant liabilities	(451,450)	0
Net income	$ 41,453	$ 4,178,527
Common Class A [Member]
Other income (expenses)
Weighted average number of Class A ordinary shares—basic and diluted	3,492,105	14,301,000
Basic and diluted net income per share, Class A	$ 0.01	$ 0.24
Weighted average number of Class B ordinary shares - basic	3,492,105	14,301,000
Weighted average number of Class B ordinary shares - diluted	3,492,105	14,301,000
Basic net income per share, Class B	$ 0.01	$ 0.24
Diluted net income per share, Class B	$ 0.01	$ 0.24
Common Class B [Member]
Other income (expenses)
Weighted average number of Class B ordinary shares - basic	3,109,884	3,450,000
Weighted average number of Class B ordinary shares - diluted	3,450,000	3,450,000
Basic net income per share, Class B	$ 0.01	$ 0.24
Diluted net income per share, Class B	$ 0.01	$ 0.24

Statements of Changes in Shareh

Statements of Changes in Shareholders' Deficit - USD ($)	Total	Ordinary Shares [Member]Common Class A [Member]	Ordinary Shares [Member]Common Class B [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]
Beginning balance at Oct. 06, 2020	$ 0	$ 0	$ 0	$ 0	$ 0
Beginning balance, Shares at Oct. 06, 2020		0	0
Issuance of Class B ordinary shares to Sponsor, Shares			3,450,000
Issuance of Class B ordinary shares to Sponsor, Value	25,000		$ 345	24,655
Sale of Private Placement Units, less fair value of derivative warrant liabilities, Shares		501,000
Sale of Private Placement Units, less fair value of derivative warrant liabilities, Value	4,731,110	$ 50		4,731,060
Accretion of Class A ordinary shares subject to possible redemption	(15,335,636)			(4,755,715)	(10,579,921)
Net income	41,453				41,453
Ending balance at Dec. 31, 2020	(10,538,073)	$ 50	$ 345	0	(10,538,468)
Ending balance, Shares at Dec. 31, 2020		501,000	3,450,000
Issuance of Class B ordinary shares to Sponsor, Value	25,000
Net income	4,178,527				4,178,527
Ending balance at Dec. 31, 2021	$ (6,359,546)	$ 50	$ 345	$ 0	$ (6,359,941)
Ending balance, Shares at Dec. 31, 2021		501,000	3,450,000

Statements of Cash Flows

Statements of Cash Flows - USD ($)	3 Months Ended	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2021
Cash Flows from Operating Activities:
Net income	$ 41,453	$ 4,178,527
Adjustments to reconcile net loss to net cash used in operating activities:
General and administrative expenses paid by Sponsor in exchange for issuance of Class B ordinary shares	25,000	0
General and administrative expenses paid by Sponsor under promissory note	18,200	0
Change in fair value of derivative warrant liabilities	(619,710)	(4,528,650)
Financing costs - derivative warrant liabilities	451,450	0
Interest income from investments held in Trust Account	(851)	(16,158)
Changes in operating assets and liabilities:
Prepaid expenses	(503,683)	242,350
Accounts payable	59,098	4,846
Accrued expenses	29,043	(19,293)
Net cash used in operating activities	(500,000)	(138,378)
Cash Flows from Investing Activities:
Cash deposited in Trust Account	(138,000,000)	0
Net cash used in investing activities	(138,000,000)	0
Cash Flows from Financing Activities:
Repayment of note payable to related party	(82,906)	0
Proceeds received from initial public offering, gross	138,000,000	0
Proceeds received from private placement	5,010,000	0
Offering costs paid	(3,062,000)	0
Net cash provided by financing activities	139,865,094	0
Net change in cash	1,365,094	(138,378)
Cash - beginning of the period	0	1,365,094
Cash - end of the period	1,365,094	1,226,716
Supplemental disclosure of noncash financing activities:
Offering costs included in accounts payable	103,380	0
Offering costs included in accrued expenses	45,000	0
Payment of offering costs through note payable	64,706	0
Deferred underwriting commissions	$ 4,830,000	$ 0

Description of Organization, Bu

Description of Organization, Business Operations and Basis of Presentation	12 Months Ended
	Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of Organization, Business Operations and Basis of Presentation	Note 1—Description of Organization, Business Operations and Basis of Presentation Organization and General Frazier Lifesciences Acquisition Corporation (the “Company”) is a blank check company incorporated as a Cayman Islands exempted company on October 7, 2020. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses that the Company has not yet identified (“Business Combination”). As of December 31, 2021, the Company had not yet commenced operations. All activity for the period from October 7, 2020 (inception) through December 31, 2021 relates to the Company’s formation and the initial public offering (the “Initial Public Offering”), which is described below, and after the Initial Public Offering, the search for a target business. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating The Company’s Sponsor is Frazier Lifesciences Sponsor LLC, a Cayman Islands limited liability company (“Sponsor”). The registration statement for the Company’s Initial Public Offering was declared effective on December 8, 2020. On December 11, 2020, the Company consummated its Initial Public Offering of 13,800,000 units (each, a “Unit” and collectively, the “Units” and, with respect to the Class A ordinary shares included in the Units being offered, the “Public Shares”), including 1,800,000 additional Units to cover over-allotments (the “Over-Allotment Units”), at $10.00 per Unit, generating gross proceeds of $138.0 million, and incurring offering costs of approximately $8.1 million, inclusive of approximately $4.8 million in deferred underwriting commissions (See Note 6). Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 501,000 units (each, a “Private Placement Unit” and collectively, the “Private Placement Units”), at a price of $10.00 per Private Placement Unit with the Sponsor, generating gross proceeds of approximately $5.0 million (See Note 4). Upon the closing of the Initial Public Offering and the Private Placement, approximately $138.0 million ($10.00 per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement were placed in a trust account (“Trust Account”) with Continental Stock Transfer & Trust Company acting as trustee and invested in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 The Company’s management has broad discretion with respect to the specific application of the net proceeds of its Initial Public Offering and the sale of Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The Company’s initial Business Combination must be with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held in the Trust Account (as defined below) (excluding taxes payable on interest earned) at the time the Company signs a definitive agreement in connection with the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target business or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended, or the Investment Company Act. The Company will provide the holders of the Public Shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a general meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The per-share Notwithstanding the foregoing, the Company’s Amended and Restated Memorandum and Articles of Association provides that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Class A ordinary shares sold in the Initial Public Offering, without the prior consent of the Company. The Company’s Sponsor, officers or directors agreed not to propose an amendment to the Company’s Amended and Restated Memorandum and Articles of Association (A) to modify the substance or timing of the Company’s obligation to allow the redemption of its Public Shares in connection with a Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination within 24 months from the closing of the Initial Public Offering, or December 11, 2022, agreement in principle or definitive agreement for an initial Business Combination within 24 months from the closing of the Initial Public Offering (the “Combination Period”), or (B) with respect to any other provisions relating to shareholders’ rights or pre-initial If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible, but not more than ten business days thereafter, redeem the Public Shares, at a per-share In connection with the redemption of 100% of the Company’s outstanding Public Shares for a portion of the funds held in the Trust Account, each holder will receive a full pro rata portion of the amount then in the Trust Account, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay the Company’s taxes payable (less taxes payable and up to $100,000 of interest to pay dissolution expenses). The Initial Shareholders agreed to waive their liquidation rights with respect to the Founder Shares and Private Placement Shares held by them if the Company fails to complete a Business Combination within the Combination Period. However, if the Initial Shareholders should acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Company’s Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution in the Trust Account will be less than the $10.00 per share initially held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or business combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the Trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. There can be no guarantee that the Company will be successful in obtaining such waivers from its targeted vendors and service providers. Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 Liquidity and Going Concern As of December 31, 2021, the Company had approximately $1.2 million in its operating bank account, and working capital of approximately $1.3 million. The Company’s liquidity needs to date have been satisfied through a contribution of $25,000 from Sponsor to cover for certain expenses in exchange for the issuance of the Founder Shares, the loan of approximately $83,000 from the Sponsor under the Note (as defined in Note 5), and the proceeds from the consummation of the Private Placement not held in the Trust Account. The Company repaid the Note in full on December 14, 2020. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (as defined in Note 5). As of December 31, 2021 and 2020, there were no amounts outstanding under any Working Capital Loan. Based on the foregoing, management believes that the Company will have sufficient working capital and borrowing capacity from the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors to meet its needs through the earlier of the consummation of a Business Combination or one year from this filing. However, in connection with the company’s assessment of going concern considerations in accordance with FASB Accounting Standards Update (“ASU”) 2014-15,

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 2—Summary of Significant Accounting Policies Basis of Presentation The accompanying financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC. Emerging Growth Company As an emerging growth company, the Company may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the Jumpstart our Business Startups Act of 2021 (the “JOBS Act”) exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging This may make comparison of the Company’s financial statement with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liability. Accordingly, the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of December 31, 2021 and 2020. Investments Held in the Trust Account The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in interest income from investments held in the Trust Account in the accompanying statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. As of December 31, 2021 and 2020, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: • Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. Offering Costs Associated with the Initial Public Offering Offering costs consisted of legal, accounting, underwriting fees and other costs incurred that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities are expensed as incurred, presented as other expenses in the statement of operations. Offering costs associated with the Public Shares were charged against the carrying value of the Class A ordinary shares subject to redemption upon the completion of the Initial Public Offering. Derivative Warrant Liabilities The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC Topic 480 and ASC Subtopic 815-15 815-15”). The warrants issued in connection with the Initial Public Offering (the “Public Warrants”) and the Private Placement Warrants (as defined in Note 4) are recognized as derivative liabilities in accordance with “Derivatives and Hedging-Contracts in Entity’s Own Equity” (“ASC Subtopic 815-40”). re-measurement Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480. Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at December 31, 2021 and 2020, 13,800,000 shares of Class A ordinary shares subject to possible redemption are presented as temporary equity, respectively, outside of the shareholders’ equity section of the Company’s balance sheets. Under ASC 480-10-S99, paid-in Income Taxes ASC Topic 740, “Income Taxes” prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts for interest and penalties as of December 31, 2021 and 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman federal income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. Net Income per Ordinary Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income per ordinary share is calculated by dividing the net income by the weighted average shares of ordinary shares outstanding for the respective period. The calculation of diluted net income does not consider the effect of the warrants underlying the Units sold in the Initial Public Offering (including the consummation of the over-allotment) and the Private Placement Warrants to purchase an aggregate of 4,767,000 Class A ordinary shares in the calculation of diluted income per share, because their exercise is contingent upon future events. The Company has considered the effect of Class B ordinary shares that were excluded from the weighted average number of basic shares outstanding as they were contingent on the exercise of over-allotment option by the underwriters. Since the contingency was satisfied, the Company has included these shares in the weighted average number as of the beginning of the period to determine the dilutive impact of these shares. Accretion associated with the redeemable Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value. The following table reflects presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per share for each class of ordinary shares: For The Year Ended For The Period From Class A Class B Class A Class B Basic and diluted net income per ordinary share: Numerator: Allocation of net income—basic $ 3,366,408 $ 812,119 $ 21,926 $ 19,527 Allocation of net income—diluted $ 3,366,408 $ 812,119 $ 20,852 $ 20,601 Denominator: Basic weighted average ordinary shares outstanding 14,301,000 3,450,000 3,492,105 3,109,884 Diluted weighted average ordinary shares outstanding 14,301,000 3,450,000 3,492,105 3,450,000 Basic net income per ordinary share $ 0.24 $ 0.24 $ 0.01 $ 0.01 Diluted net income per ordinary share $ 0.24 $ 0.24 $ 0.01 $ 0.01 Recent Issued Accounting Standards In August 2020, the FASB issued Accounting Standard Update (the “ASU”) No. 2020-06, 470-20) 815-40): The Company’s management does not believe that any recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the accompanying financial statements.

Initial Public Offering

Initial Public Offering	12 Months Ended
	Dec. 31, 2021
Initial Public Offering [Abstract]
Initial Public Offering	Note 3—Initial Public Offering On December 11, 2020, the Company consummated its Initial Public Offering of 13,800,000 Units, including 1,800,000 Over-Allotment Units, at $10.00 per Unit, generating gross proceeds of $138.0 million, and incurring offering costs of approximately $8.1 million, inclusive of approximately $4.8 million in deferred underwriting commissions. Each Unit consists of one Class A ordinary share and one-third

Private Placement

Private Placement	12 Months Ended
	Dec. 31, 2021
Private Placement [Abstract]
Private Placement	Note 4—Private Placement Simultaneously with the closing of the Initial Public Offering, the Company consummated the Private Placement of 501,000 Private Placement Units, at a price of $10.00 per Private Placement Unit with the Sponsor, generating gross proceeds of approximately $5.0 million. Each Private Placement Unit consists of one Class A ordinary share and one-third non-redeemable The Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Units until 30 days after the completion of the initial Business Combination.

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2021
Related Party Transactions [Abstract]
Related Party Transactions	Note 5—Related Party Transactions Founder Shares On October 7, 2020, the Sponsor paid an aggregate of $25,000 for certain expenses on behalf of the Company in exchange for issuance of 2,875,000 Class B ordinary shares (the “Founder Shares”). On November 20, 2020, the Sponsor transferred 30,000 Founder Shares to each of the directors other than the Chairman. On December 8, 2020, the Company effected a share sub-division, sub-division. The Initial Shareholders agreed not to transfer, assign or sell any of their Founder Shares until the earlier to occur of: (A) one year after the completion of the initial Business Combination or (B) subsequent to the initial Business Combination, (x) if the closing price of Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, 30-trading Related Party Loans On October 7, 2020, the Sponsor agreed to loan the Company up to $300,000 to be used for the payment of costs related to the Initial Public Offering pursuant to a promissory note (the “Note”). The Note is non-interest In addition, in order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company may repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans may be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into private placement units of the post Business Combination entity at a price of $10.00 per unit. The private placement units would be identical to the public units sold, subject to certain limited exceptions. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. As of December 31, 2021 and 2020, the Company had no borrowings under the Working Capital Loans. Administrative Services Agreement The Company entered into an agreement that provided that, commencing on the date that the Company’s securities were first listed on the Nasdaq through the earlier of consummation of the initial Business Combination and the liquidation, the Company agreed to pay the Sponsor $10,000 per month for office space, secretarial and administrative services provided to the Company. During the year ended December 31, 2021 and 2020, the Company incurred approximately $120,000 and $7,000 for expenses in connection with the Administrative Services Agreement. As of December 31, 2021 and 2020, there was approximately $-0- In addition, the Sponsor, officers and directors, or any of their respective affiliates will be reimbursed for any out-of-pocket

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 6—Commitments and Contingencies Registration and Shareholder Rights The holders of the Founder Shares, Private Placement Units, Private Placement Shares, Private Placement Warrants, Class A ordinary shares underlying the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans) are entitled to registration rights pursuant to a registration and shareholder rights agreement signed upon the effective date of the Initial Public Offering. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The Company granted the underwriters a 45-day The underwriters will be entitled to an underwriting discount of $0.20 per unit, or approximately $2.8 million in the aggregate, paid upon the closing of the Initial Public Offering. In addition, $0.35 per unit, or approximately $4.8 million in the aggregate will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 while it is reasonably possible that these events could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of the financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Class A Ordinary Shares Subject

Class A Ordinary Shares Subject To Possible Redemption	12 Months Ended
	Dec. 31, 2021
Temporary Equity Disclosure [Abstract]
Class A Ordinary Shares Subject To Possible Redemption	Note 7—Class A Ordinary Shares Subject To Possible Redemption The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of future events. The Company is authorized to issue 479,000,000 ordinary shares with a par value of $0.0001 per share. Holders of the Company’s Class A ordinary shares are entitled to one vote for each share. As of December 31, 2021 and 2020, there were 14,301,000 Class A ordinary shares issued and outstanding, of which 13,800,000 shares were subject to possible redemption have been classified as temporary equity. Class A ordinary shares subject to possible redemption reflected on the balance sheet is reconciled on the following table: Gross proceeds $ 138,000,000 Less: Fair value of Public Warrants at issuance (7,682,000 ) Offering costs allocated to Class A ordinary shares subject to possible (7,653,636 ) Plus: Accretion on Class A ordinary shares subject to possible redemption amount 15,335,636 Class A ordinary shares subject to possible redemption $ 138,000,000

Derivative Warrant Liabilities

Derivative Warrant Liabilities	12 Months Ended
	Dec. 31, 2021
Derivative Warrant Liabilities [Abstract]
Derivative Warrant Liabilities	Note 8—Derivative Warrant Liabilities As of December 31, 2021 and 2020, the Company has 4,600,000 and 167,000 Public Warrants and Private Placement Warrants, respectively, outstanding. Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination and (b) 12 months from the closing of the Initial Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the Public Warrants and a current prospectus relating to them is available and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder (or the Company permits holders to exercise their warrants on a cashless basis under certain circumstances). The Company agreed that as soon as practicable, but in no event later than 20 business days after the closing of the initial Business Combination, the Company will use commercially reasonable efforts to file with the SEC a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants and to maintain a current prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the 60th day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, it will use commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. The warrants have an exercise price of $11.50 per share, subject to adjustments, and will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the Initial Shareholders or their affiliates, without taking into account any Founder Shares held by the Initial Shareholders or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of Class A ordinary shares during the 10-trading The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except (i) that the Private Placement Warrants and the Class A ordinary shares issuable upon exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions, (ii) except as described below, the Private Placement Warrants will be non-redeemable Redemption of warrants for cash when the price per Class A ordinary share equals or exceeds $18.00: Once the warrants become exercisable, the Company may call the outstanding warrants for redemption (except as described herein with respect to the Private Placement Warrants): • in whole and not in part; • at a price of $0.01 per warrant; • upon a minimum of 30 days’ prior written notice of redemption to each warrant holder; and • if, and only if, the last reported sales price (the “closing price”) of Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for share sub-divisions, 30-trading The Company will not redeem the warrants as described above unless a registration statement under the Securities Act covering the issuance of the Class A ordinary shares issuable upon exercise of the warrants is then effective and a current prospectus relating to those Class A ordinary shares is available throughout the 30-day Redemption of warrants for Class A ordinary shares when the price per Class A ordinary share equals or exceeds $10.00: After the warrants become exercisable, the Company may redeem the outstanding warrants: • in whole and not in part; • at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of Class A ordinary shares to be determined by reference to an agreed table based on the redemption date and the “fair market value” of Class A ordinary shares; • if, and only if, the closing price of Class A ordinary shares equals or exceeds $10.00 per Public Share (as adjusted per share subdivisions, share dividends, reorganizations, recapitalizations and the like) on the trading day before the Company sends the notice of redemption to the warrant holders; and • if the Reference Value is less than $18.00 per share (as adjusted for share splits, share dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like), then the Private Placement Warrants must also concurrently be called for redemption on the same terms (except as described herein with respect to a holder’s ability to cashless exercise its warrants) as the outstanding Public Warrants as described above. The “fair market value” of Class A ordinary shares for the above purpose shall mean the volume weighted average price of Class A ordinary shares during the 10 trading days immediately following the date on which the notice of redemption is sent to the holders of warrants. In no event will the warrants be exercisable on a cashless basis in connection with this redemption feature for more than 0.361 Class A ordinary shares per warrant (subject to adjustment). In no event will the Company be required to net cash settle any warrant. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.

Shareholders' Deficit

Shareholders' Deficit	12 Months Ended
	Dec. 31, 2021
Stockholders' Equity Note [Abstract]
Shareholders' Deficit	Note 9—Shareholders’ Deficit Preference Shares Class A Ordinary Shares Class B Ordinary Shares sub-division, sub-division. two-thirds The Class B ordinary shares will automatically convert into Class A ordinary shares on the first business day following the consummation of the initial Business Combination at a ratio such that the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, on an as-converted one-to-one.

Fair Value Measurements

Fair Value Measurements	12 Months Ended
	Dec. 31, 2021
Fair Value Disclosures [Abstract]
Fair Value Measurements	Note 10—Fair Value Measurements The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of December 31, 2021 and 2020 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value. December 31, 2021 Description Quoted Prices in (Level 1) Significant Other (Level 2) Significant Other (Level 3) Assets: Investments held in Trust Account $ 138,017,009 $ — $ — Liabilities: Derivative warrant liabilities $ 2,714,000 $ 98,530 $ — December 31, 2020 Description Quoted Prices in Active Markets (Level 1) Significant Other Observable Inputs (Level 2) Significant Other Unobservable (Level 3) Assets: Investments held in Trust Account $ 138,000,851 $ — $ — Liabilities: Derivative warrant liabilities $ — $ — $ 7,341,180 Transfers to/from Levels 1, 2, and 3 are recognized at the beginning of the reporting period. The estimated fair value of the Public Warrants of $7,084,000 transferred from a Level 3 measurement to a Level 1 fair value measurement in January 2021, when the Public Warrants were separately listed and traded. The estimated fair value of the Private Warrants of $257,180 was transferred from a Level 3 measurement to a Level 2 fair value measurement as of January 2021, as the transfer of Private Placement Warrants to anyone who is not a permitted transferee would result in the Private Placement Warrants having substantially the same terms as the Public Warrants, the Company determined that the fair value of each Private Placement Warrant is equivalent to that of each Public Warrant. Level 1 instruments include investments in mutual funds invested in government securities. The Company uses inputs such as actual trade data, benchmark yields, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments. Other than the transfer of the Public Warrants (Level 3 to Level 1) and Private Placement Warrants (Level 3 to Level 2), there were no transfers to/from Level 1, 2, and 3 in the year ended December 31, 2021.​​​​​​​ The change in the fair value of the derivative warrant liabilities for the year ended December 31, 2021 is summarized as follows: Derivative warrant liabilities at December 31, 2020 $ 7,341,180 Transfer of Public Warrants to level 1 (7,084,000 ) Transfer of Private Warrant to level 2 (257,180 ) Change in fair value of derivative warrant liabilities — Derivative warrant liabilities at December 31, 2021 $ —

Break-up Fee

Break-up Fee	12 Months Ended
	Dec. 31, 2021
Disclosure of Break Up Fee [Abstract]
Break-up Fee	Note 11 – Break-up On September 13, 2021, the Company entered into a term sheet in connection with an initial business combination. This term sheet was terminated on December 30, 2021 and in accordance with the term sheet, the Company received a break-up

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2021
Subsequent Events [Abstract]
Subsequent Events	Note 12—Subsequent Events The Company evaluated subsequent events and transactions that occurred up to the date the financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC.
Emerging Growth Company	Emerging Growth Company As an emerging growth company, the Company may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the Jumpstart our Business Startups Act of 2021 (the “JOBS Act”) exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging This may make comparison of the Company’s financial statement with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of estimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liability. Accordingly, the actual results could differ significantly from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of December 31, 2021 and 2020.
Investments Held in the Trust Account	Investments Held in the Trust Account The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in interest income from investments held in the Trust Account in the accompanying statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. As of December 31, 2021 and 2020, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.
Fair Value Measurements	Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: • Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
Offering costs associated with Initial Public Offering	Offering Costs Associated with the Initial Public Offering Offering costs consisted of legal, accounting, underwriting fees and other costs incurred that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities are expensed as incurred, presented as other expenses in the statement of operations. Offering costs associated with the Public Shares were charged against the carrying value of the Class A ordinary shares subject to redemption upon the completion of the Initial Public Offering.
Class A Ordinary Shares Subject to Possible Redemption	Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480. Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at December 31, 2021 and 2020, 13,800,000 shares of Class A ordinary shares subject to possible redemption are presented as temporary equity, respectively, outside of the shareholders’ equity section of the Company’s balance sheets. Under ASC 480-10-S99, paid-in
Derivative Warrant Liabilities	Derivative Warrant Liabilities The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC Topic 480 and ASC Subtopic 815-15 815-15”). The warrants issued in connection with the Initial Public Offering (the “Public Warrants”) and the Private Placement Warrants (as defined in Note 4) are recognized as derivative liabilities in accordance with “Derivatives and Hedging-Contracts in Entity’s Own Equity” (“ASC Subtopic 815-40”). re-measurement
Net income (loss) per ordinary share	Net Income per Ordinary Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income per ordinary share is calculated by dividing the net income by the weighted average shares of ordinary shares outstanding for the respective period. The calculation of diluted net income does not consider the effect of the warrants underlying the Units sold in the Initial Public Offering (including the consummation of the over-allotment) and the Private Placement Warrants to purchase an aggregate of 4,767,000 Class A ordinary shares in the calculation of diluted income per share, because their exercise is contingent upon future events. The Company has considered the effect of Class B ordinary shares that were excluded from the weighted average number of basic shares outstanding as they were contingent on the exercise of over-allotment option by the underwriters. Since the contingency was satisfied, the Company has included these shares in the weighted average number as of the beginning of the period to determine the dilutive impact of these shares. Accretion associated with the redeemable Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value. The following table reflects presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per share for each class of ordinary shares: For The Year Ended For The Period From Class A Class B Class A Class B Basic and diluted net income per ordinary share: Numerator: Allocation of net income—basic $ 3,366,408 $ 812,119 $ 21,926 $ 19,527 Allocation of net income—diluted $ 3,366,408 $ 812,119 $ 20,852 $ 20,601 Denominator: Basic weighted average ordinary shares outstanding 14,301,000 3,450,000 3,492,105 3,109,884 Diluted weighted average ordinary shares outstanding 14,301,000 3,450,000 3,492,105 3,450,000 Basic net income per ordinary share $ 0.24 $ 0.24 $ 0.01 $ 0.01 Diluted net income per ordinary share $ 0.24 $ 0.24 $ 0.01 $ 0.01 Recent Issued Accounting Standards
Income Taxes	Income Taxes ASC Topic 740, “Income Taxes” prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts for interest and penalties as of December 31, 2021 and 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman federal income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Recent Issued Accounting Standards	In August 2020, the FASB issued Accounting Standard Update (the “ASU”) No. 2020-06, 470-20) 815-40): The Company’s management does not believe that any recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the accompanying financial statements.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
Summary of Basic and Diluted Net Income Per Share	The following table reflects presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per share for each class of ordinary shares: For The Year Ended For The Period From Class A Class B Class A Class B Basic and diluted net income per ordinary share: Numerator: Allocation of net income—basic $ 3,366,408 $ 812,119 $ 21,926 $ 19,527 Allocation of net income—diluted $ 3,366,408 $ 812,119 $ 20,852 $ 20,601 Denominator: Basic weighted average ordinary shares outstanding 14,301,000 3,450,000 3,492,105 3,109,884 Diluted weighted average ordinary shares outstanding 14,301,000 3,450,000 3,492,105 3,450,000 Basic net income per ordinary share $ 0.24 $ 0.24 $ 0.01 $ 0.01 Diluted net income per ordinary share $ 0.24 $ 0.24 $ 0.01 $ 0.01

Class A Ordinary Shares Subje_2

Class A Ordinary Shares Subject To Possible Redemption (Tables)	12 Months Ended
	Dec. 31, 2021
Temporary Equity Disclosure [Abstract]
Summary Of Class A Ordinary Shares Subject To Possible Redemption	Class A ordinary shares subject to possible redemption reflected on the balance sheet is reconciled on the following table: Gross proceeds $ 138,000,000 Less: Fair value of Public Warrants at issuance (7,682,000 ) Offering costs allocated to Class A ordinary shares subject to possible (7,653,636 ) Plus: Accretion on Class A ordinary shares subject to possible redemption amount 15,335,636 Class A ordinary shares subject to possible redemption $ 138,000,000

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	12 Months Ended
	Dec. 31, 2021
Fair Value Disclosures [Abstract]
Summary of quantitative information regarding fair value measurements	The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of December 31, 2021 and 2020 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value. December 31, 2021 Description Quoted Prices in (Level 1) Significant Other (Level 2) Significant Other (Level 3) Assets: Investments held in Trust Account $ 138,017,009 $ — $ — Liabilities: Derivative warrant liabilities $ 2,714,000 $ 98,530 $ — December 31, 2020 Description Quoted Prices in Active Markets (Level 1) Significant Other Observable Inputs (Level 2) Significant Other Unobservable (Level 3) Assets: Investments held in Trust Account $ 138,000,851 $ — $ — Liabilities: Derivative warrant liabilities $ — $ — $ 7,341,180
Summary of changes in fair value of the derivative warrant liabilities	The change in the fair value of the derivative warrant liabilities for the year ended December 31, 2021 is summarized as follows: Derivative warrant liabilities at December 31, 2020 $ 7,341,180 Transfer of Public Warrants to level 1 (7,084,000 ) Transfer of Private Warrant to level 2 (257,180 ) Change in fair value of derivative warrant liabilities — Derivative warrant liabilities at December 31, 2021 $ —

Description of Organization, _2

Description of Organization, Business Operations and Basis of Presentation - Additional Information (Detail) - USD ($)	Dec. 11, 2020	Dec. 31, 2020	Dec. 31, 2021
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Sale of stock issue price per share	$ 10
Proceeds from initial public offer	$ 138,000,000	$ 138,000,000	$ 0
Adjustments to additional paid in capital stock issuance costs	8,100,000
Deferred underwriting commissions	$ 4,800,000	4,830,000	4,830,000
Proceeds from private placement		5,010,000	0
Payment to acquire restricted investments		$ 138,000,000	$ 0
Restricted investment value per share			$ 10
Term of restricted investments		185 days	185 days
Temporary equity redemption price per share		$ 10	$ 10
Minimum net worth necessary to carry out business combination			$ 5,000,001
Percentage of public shares to be redeemed in case business combination is not consummated			100.00%
Period within which business combination shall be consummated from the date of initial public offer			24 months
Expenses payable on liquidation			$ 100,000
Minimum per share amount to be maintained in the trust account			$ 10
Cash at bank		$ 1,365,094	$ 1,226,716
Net working capital			1,300,000
Proceeds from related party debt			83,000
Stock issued during period, value, issued for services		$ 25,000	$ 25,000
Minimum [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Fair value of net assets of the acquire as a percentage of assets in the trust account			80.00%
Equity method investment ownership percentage			50.00%
IPO [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Proceeds from initial public offer			$ 138,000,000
Common Class A [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Percentage of shares eligible to be transferred without any restriction			15.00%
Common Class A [Member] | IPO [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Stock issued during the period shares	13,800,000
Common Class A [Member] | Over-Allotment Option [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Stock issued during the period shares	1,800,000
Class A Common Stock And One Third Of One Redeemable Warrant | Private Placement [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Stock issued during the period shares		501,000
Sale of stock issue price per share		$ 10	$ 10

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($)	3 Months Ended	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2021
Accounting Policies [Line Items]
Term of restricted investments	185 days	185 days
Cash insured with federal depository insurance corporation		$ 250,000
Temporary equity shares outstanding	13,800,000	13,800,000
Unrecognized tax benefits		$ 0
Accrued interest and penalties on unrecognized tax benefits	$ 0
Cash equivalents in its operating account	$ 0	$ 0
Class A Common Stock Subject to Possible Redemption [Member]
Accounting Policies [Line Items]
Temporary equity shares outstanding	13,800,000	13,800,000
Warrant [Member]
Accounting Policies [Line Items]
Antidilutive securities excluded from the computation of earnings per share		4,767,000

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Summary of Basic and Diluted Net Income Per Share (Detail) - USD ($)	3 Months Ended	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2021
Common Class A [Member]
Numerator:
Allocation of net income - basic	$ 21,926	$ 3,366,408
Allocation of net income - diluted	$ 20,852	$ 3,366,408
Denominator:
Basic weighted average ordinary shares outstanding	3,492,105	14,301,000
Diluted weighted average ordinary shares outstanding	3,492,105	14,301,000
Basic net income per ordinary share	$ 0.01	$ 0.24
Diluted net income per ordinary share	$ 0.01	$ 0.24
Common Class B [Member]
Numerator:
Allocation of net income - basic	$ 19,527	$ 812,119
Allocation of net income - diluted	$ 20,601	$ 812,119
Denominator:
Basic weighted average ordinary shares outstanding	3,109,884	3,450,000
Diluted weighted average ordinary shares outstanding	3,450,000	3,450,000
Basic net income per ordinary share	$ 0.01	$ 0.24
Diluted net income per ordinary share	$ 0.01	$ 0.24

Initial Public Offering - Addit

Initial Public Offering - Additional Information (Detail) - USD ($)	Dec. 11, 2020	Dec. 31, 2020	Dec. 31, 2021
Initial Public Offering [Line Items]
Sale of stock issue price per share	$ 10
Proceeds from initial public offer	$ 138,000,000	$ 138,000,000	$ 0
Adjustments to additional paid in capital stock issuance costs	8,100,000
Deferred underwriting commissions	$ 4,800,000	$ 4,830,000	$ 4,830,000
Class of warrant or right, exercise price of warrants or rights			$ 11.50
IPO [Member]
Initial Public Offering [Line Items]
Proceeds from initial public offer			$ 138,000,000
Common Class A [Member]
Initial Public Offering [Line Items]
Class of warrant or right, exercise price of warrants or rights	$ 11.50	$ 11.50
Common Class A [Member] | IPO [Member]
Initial Public Offering [Line Items]
Stock issued during the period shares	13,800,000
Common Class A [Member] | Over-Allotment Option [Member]
Initial Public Offering [Line Items]
Stock issued during the period shares	1,800,000

Private Placement - Additional

Private Placement - Additional Information (Detail) - USD ($)	3 Months Ended	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2021	Dec. 11, 2020
Private Placement [Line Items]
Sale of stock issue price per share			$ 10
Proceeds from private placement	$ 5,010,000	$ 0
Class of warrant or right, exercise price of warrants or rights		$ 11.50
Class A Common Stock and One Third of One Redeemable Warrant [Member] | Private Placement [Member]
Private Placement [Line Items]
Stock issued during the period shares	501,000
Sale of stock issue price per share	$ 10	$ 10
Common Class A [Member]
Private Placement [Line Items]
Class of warrant or right, exercise price of warrants or rights	$ 11.50		$ 11.50

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Detail) - USD ($)	Oct. 07, 2020	Dec. 31, 2020	Dec. 31, 2021	Dec. 08, 2020	Dec. 07, 2020	Nov. 20, 2020
Payments of stock issuance costs		$ 3,062,000	$ 0
Proceeds from related party debt			83,000
Agreed amount to repay for administrative services			10,000
Administrative expenses—related party		6,774	120,000
Accrued expenses		74,043	54,750
Administration And Support Services [Member]
Accrued expenses		7,000	0
Related Party Loan [Member]
Line of credit facility, maximum borrowing capacity	$ 300,000
Proceeds from related party debt	$ 83,000
Working Capital Loan [Member]
Share Price	$ 10
Convertible debt	$ 1,500,000
Long-term debt, gross		$ 0	$ 0
Founder Shares [Member]
Payments of stock issuance costs	$ 25,000
Number of shares transferred						30,000
Common Class A [Member]
Common stock shares outstanding		501,000	501,000
Share Price			$ 9.20
Common Class A [Member] | Minimum [Member]
Share Price				$ 12
Common Class B [Member]
Common stock shares outstanding		3,450,000	3,450,000	3,450,000	2,875,000
Number of shares forfeited				450,000
Percent of founder shares to issued and outstanding shares				20.00%
Common Class B [Member] | Founder Shares [Member]
Stock issued during the period shares	2,875,000
Common stock shares outstanding				3,450,000	2,875,000
Number of shares forfeited				450,000
Percent of founder shares to issued and outstanding shares				20.00%

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Millions	Dec. 11, 2020	Dec. 31, 2021
Loss Contingencies [Line Items]
Underwriting discount per unit		$ 0.20
Underwriting discount value		$ 2.8
Deferred underwriting commissions per unit		$ 0.35
Deferred underwriting commissions value		$ 4.8
Over-Allotment Option [Member] | Common Class A [Member]
Loss Contingencies [Line Items]
Stock issued during the period shares	1,800,000

Class A Ordinary Shares Subje_3

Class A Ordinary Shares Subject To Possible Redemption - Summary Of Class A Ordinary Shares Subject To Possible Redemption (Detail) - USD ($)	Dec. 11, 2020	Dec. 31, 2020	Dec. 31, 2021
Temporary Equity [Line Items]
Gross proceeds	$ 138,000,000	$ 138,000,000	$ 0
Proceeds allocated to public warrants		(619,710)	(4,528,650)
Class A ordinary share subject to possible redemption		$ 138,000,000	138,000,000
IPO [Member]
Temporary Equity [Line Items]
Gross proceeds			138,000,000
Proceeds allocated to public warrants			(7,682,000)
Common Class A [Member]
Temporary Equity [Line Items]
Class A ordinary share issuance costs			(7,653,636)
Accretion of carrying value to redemption value			15,335,636
Class A ordinary share subject to possible redemption			$ 138,000,000

Class A Ordinary Shares Subje_4

Class A Ordinary Shares Subject To Possible Redemption - Additional Information (Detail) - $ / shares	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Redeemable Noncontrolling Interest [Line Items]
Temporary Equity, Shares Outstanding	13,800,000	13,800,000
Temporary Equity, Shares Issued	13,800,000	13,800,000
Common Class A [Member]
Redeemable Noncontrolling Interest [Line Items]
Common Stock, Shares Authorized	479,000,000	479,000,000
Common Stock, No Par Value	$ 0.0001
Common Stock, Voting Rights	one vote
Temporary Equity, Shares Outstanding	13,800,000	13,800,000
Temporary Equity Shares Subject To Possible Redemption	14,301,000
Temporary Equity, Shares Issued	13,800,000

Derivative Warrant Liabilities

Derivative Warrant Liabilities - Additional Information (Detail) - $ / shares	Dec. 31, 2021	Dec. 31, 2020	Dec. 11, 2020
Derivative Warrant Liabilities [Line Items]
Exercise Price of Warrants or Rights	$ 11.50
Warrants and Rights Outstanding, Term	5 years
Percent of gross proceeds from such issuances to total equity proceeds	60.00%
Number of Securities Called by Each Warrant or Right	0.361
Share Trigger Price One [Member]
Derivative Warrant Liabilities [Line Items]
Share Price	$ 9.20
Percent of exercise price of the warrants adjusted to share price	115.00%
Share Trigger Price Two [Member]
Derivative Warrant Liabilities [Line Items]
Exercise Price of Warrants or Rights	$ 0.01
Share Price	$ 18
Percent of exercise price of the warrants adjusted to share price	180.00%
Share Trigger Price Three [Member]
Derivative Warrant Liabilities [Line Items]
Exercise Price of Warrants or Rights	$ 0.10
Share Price	10
Common Class A [Member]
Derivative Warrant Liabilities [Line Items]
Exercise Price of Warrants or Rights		$ 11.50	$ 11.50
Share Price	$ 9.20
Public Warrants [Member]
Derivative Warrant Liabilities [Line Items]
Class of Warrant or Right, Outstanding	4,600,000
Private Placement Warrants [Member]
Derivative Warrant Liabilities [Line Items]
Class of Warrant or Right, Outstanding		167,000

Shareholders' Deficit - Additio

Shareholders' Deficit - Additional Information (Detail) - $ / shares	Dec. 31, 2021	Dec. 31, 2020	Dec. 08, 2020	Dec. 07, 2020	Oct. 07, 2020
Class of Stock [Line Items]
Preferred stock shares authorized	1,000,000	1,000,000
Preferred stock par or stated value per share	$ 0.0001	$ 0.0001
Preferred stock shares issued	0	0
Preferred stock shares outstanding	0	0
Temporary equity par or stated value per share	$ 0.0001	$ 0.0001
Common stock shares outstanding including temporary equity		14,301,000
Temporary equity shares outstanding	13,800,000	13,800,000
Percent of shares convertible	20.00%
Common Class A [Member]
Class of Stock [Line Items]
Temporary Equity, Shares Authorized	479,000,000
Temporary equity par or stated value per share	$ 0.0001
Common stock shares issued including temporary equity	14,301,000	14,301,000
Common stock shares outstanding including temporary equity	14,301,000
Temporary equity shares outstanding	13,800,000	13,800,000
Common stock shares authorized	479,000,000	479,000,000
Common stock par or stated value per share	$ 0.0001	$ 0.0001
Common stock shares issued	501,000	501,000
Common stock shares outstanding	501,000	501,000
Common Class B [Member]
Class of Stock [Line Items]
Common stock shares authorized	20,000,000	20,000,000
Common stock par or stated value per share	$ 0.0001	$ 0.0001
Common stock shares issued	3,450,000	3,450,000			2,875,000
Common stock shares outstanding	3,450,000	3,450,000	3,450,000	2,875,000
Number of shares forfeited			450,000
Percent of founder shares to issued and outstanding shares			20.00%
Number of shares no longer subject to forfeiture	450,000

Fair Value Measurements - Summa

Fair Value Measurements - Summary Of Quantitative Information Regarding Fair Value Measurements (Detail) - Fair Value, Recurring [Member] - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Fair Value, Inputs, Level 1 [Member] | Investments Held in Trust Account [Member]
Assets:
Cash held in Trust Account	$ 138,017,009	$ 138,000,851
Fair Value, Inputs, Level 1 [Member] | Derivative Warrant Liabilities [Member]
Liabilities:
Derivative warrant liabilities	2,714,000	0
Fair Value, Inputs, Level 2 [Member] | Investments Held in Trust Account [Member]
Assets:
Cash held in Trust Account	0	0
Fair Value, Inputs, Level 2 [Member] | Derivative Warrant Liabilities [Member]
Liabilities:
Derivative warrant liabilities	98,530	0
Fair Value, Inputs, Level 3 [Member] | Investments Held in Trust Account [Member]
Assets:
Cash held in Trust Account	0	0
Fair Value, Inputs, Level 3 [Member] | Derivative Warrant Liabilities [Member]
Liabilities:
Derivative warrant liabilities	$ 0	$ 7,341,180

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Detail)	12 Months Ended
	Dec. 31, 2021USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of public warrants	$ 7,084,000
Fair value of private warrants	257,180
FLAC Investments Held In Trust Account [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Transfers between levels	$ 0

Fair value measurements - Sum_2

Fair value measurements - Summary of Changes In The Fair Value of Warrant Liabilities (Detail)	12 Months Ended
	Dec. 31, 2021USD ($)
Disclosure Of Change In The Fair Value Of The Derivative Warrant Liabilities [Line Items]
Derivative warrant liabilities, Beginning	$ 7,341,180
Transfer of Public Warrants to level 1	(7,084,000)
Transfer of Private Warrant to level 2	(257,180)
Change in fair value of derivative warrant liabilities	0
Derivative warrant liabilities, Ending	$ 0

Break-up Fee – Additional

Break-up Fee – Additional Information (Detail) - USD ($)	3 Months Ended	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2021
Disclosure of Break Up Fee [Abstract]
Break UpFee from Terminated Agreement	$ 0	$ 1,000,000